Search results
... Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with...
Benzinga· 5 hours agoDr. Kim Linton, M.B.Ch.B, MRCP, Ph.D., ...
Processa reports positive Phase 1b trial results for cancer drug By Investing.com
Investing.com· 5 days agoProcessa Pharmaceuticals, Inc. (NASDAQ:PCSA), a clinical-stage pharmaceutical company, has announced...
Kymera reports promising Phase 1 results for KT-333 cancer drug By Investing.com
Investing.com· 2 days agoKymera Therapeutics Inc. (NASDAQ: KYMR), a biopharmaceutical firm focused on advancing protein...
FDA grants IND clearance for Allay’s trial of post-surgical pain treatment
Clinical Trials Arena via Yahoo Finance· 3 days agoThe upcoming three-arm, randomised, controlled Phase IIb registration trial will enrol 200...
Federal Court Invalidates Dosing Patent Based On Clinical Trials Disclosure | JD Supra
JD Supra· 6 days agoAs an essential component of the drug development process, human clinical trials assist in determining whether a given drug will serve its intended...
Cybin appoints new SVP for clinical development By Investing.com
Investing.com· 5 days agoAtul R. Mahableshwarkar as Senior Vice President of Clinical Development. Dr. Mahableshwarkar, a...
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat...
Digital Journal· 4 days agoThe FDA has recommended that the evaluation of Bucillamine for Long COVID be submitted as a new Investigational New Drug (“IND”) application and may cross-reference applicable sections from ...
Mounjaro Is Targeting Another Multibillion-Dollar Market: Is Eli Lilly Stock a Buy?
Motley Fool via Yahoo Finance· 20 hours agoTirzepatide is being developed to treat other conditions, including obstructive sleep apnea. The...
ProKidney Corp. (NASDAQ:PROK) Director Buys $54,735,339.78 in Stock
ETF DAILY NEWS· 1 day agoProKidney Corp. (NASDAQ:PROK – Get Free Report) Director Pablo G. Legorreta bought 22,617,909 shares of the business’s stock in a transaction dated Thursday, June 13th. The stock was acquired ...
Axiom Real-Time Metrics Announces Leadership Transition
Morningstar· 4 days agoAxiom Real-Time Metrics Announces Leadership Transition Axiom Real-Time Metrics (“Axiom”), a premier provider of unified eClinical solutions and services that are used to enhance the efficiency ...